Dudediligence.

Neurocrine Biosciences, Inc

NBIXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 28 →InsidersNo open-market buys. 14 insiders sold $69.9M, 27 of 28 sales on a 10b5-1 plan.→HoldersBlackRock 13.5%Jpmorgan Chase & 6.3%Dodge & Cox 5.5%→PeersClosest companies: RIGL, ACAD, ALNY→

From the filings

Figures

Revenue
$3.37Blast 12 months
Net income
$705.5Mlast 12 months
Operating cash flow
$863.7Mlast 12 months
Cash and equivalents
$332.4Mat the last balance sheet
Shares outstanding
101.6M shareson issue
Every year and quarter →